These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 36604563)
1. Time to diagnosis of Duchenne muscular dystrophy in Austria and Germany. Hiebeler M; Thiele S; Reilich P; Bernert G; Walter MC Sci Rep; 2023 Jan; 13(1):179. PubMed ID: 36604563 [TBL] [Abstract][Full Text] [Related]
2. Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database. Koeks Z; Bladen CL; Salgado D; van Zwet E; Pogoryelova O; McMacken G; Monges S; Foncuberta ME; Kekou K; Kosma K; Dawkins H; Lamont L; Bellgard MI; Roy AJ; Chamova T; Guergueltcheva V; Chan S; Korngut L; Campbell C; Dai Y; Wang J; Barišić N; Brabec P; Lähdetie J; Walter MC; Schreiber-Katz O; Karcagi V; Garami M; Herczegfalvi A; Viswanathan V; Bayat F; Buccella F; Ferlini A; Kimura E; van den Bergen JC; Rodrigues M; Roxburgh R; Lusakowska A; Kostera-Pruszczyk A; Santos R; Neagu E; Artemieva S; Rasic VM; Vojinovic D; Posada M; Bloetzer C; Klein A; Díaz-Manera J; Gallardo E; Karaduman AA; Oznur T; Topaloğlu H; El Sherif R; Stringer A; Shatillo AV; Martin AS; Peay HL; Kirschner J; Flanigan KM; Straub V; Bushby K; Béroud C; Verschuuren JJ; Lochmüller H J Neuromuscul Dis; 2017; 4(4):293-306. PubMed ID: 29125504 [TBL] [Abstract][Full Text] [Related]
4. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Ryder S; Leadley RM; Armstrong N; Westwood M; de Kock S; Butt T; Jain M; Kleijnen J Orphanet J Rare Dis; 2017 Apr; 12(1):79. PubMed ID: 28446219 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Manzur AY; Kuntzer T; Pike M; Swan A Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031 [TBL] [Abstract][Full Text] [Related]
6. The natural history of the patients with Duchenne muscular dystrophy in Taiwan: A medical center experience. Liang WC; Wang CH; Chou PC; Chen WZ; Jong YJ Pediatr Neonatol; 2018 Apr; 59(2):176-183. PubMed ID: 28903883 [TBL] [Abstract][Full Text] [Related]
8. Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy. Kim S; Zhu Y; Romitti PA; Fox DJ; Sheehan DW; Valdez R; Matthews D; Barber BJ; Neuromuscul Disord; 2017 Aug; 27(8):730-737. PubMed ID: 28645460 [TBL] [Abstract][Full Text] [Related]
9. A qualitative study to understand the Duchenne muscular dystrophy experience from the parent/patient perspective. Brown V; Merikle E; Johnston K; Gooch K; Audhya I; Lowes L J Patient Rep Outcomes; 2023 Dec; 7(1):129. PubMed ID: 38085412 [TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Manzur AY; Kuntzer T; Pike M; Swan A Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215 [TBL] [Abstract][Full Text] [Related]
11. Racial and Ethnic Differences in Timing of Diagnosis and Clinical Services Received in Duchenne Muscular Dystrophy. Mann JR; Zhang Y; McDermott S; Wang Y; Cai B; Conway KM; Paramsothy P; Royer J; Venkatesh S; Howard JF; Ciafaloni E; Neuroepidemiology; 2023; 57(2):90-99. PubMed ID: 36623491 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study. Smith EC; Conklin LS; Hoffman EP; Clemens PR; Mah JK; Finkel RS; Guglieri M; Tulinius M; Nevo Y; Ryan MM; Webster R; Castro D; Kuntz NL; Kerchner L; Morgenroth LP; Arrieta A; Shimony M; Jaros M; Shale P; Gordish-Dressman H; Hagerty L; Dang UJ; Damsker JM; Schwartz BD; Mengle-Gaw LJ; McDonald CM; PLoS Med; 2020 Sep; 17(9):e1003222. PubMed ID: 32956407 [TBL] [Abstract][Full Text] [Related]
14. Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy. Barber BJ; Andrews JG; Lu Z; West NA; Meaney FJ; Price ET; Gray A; Sheehan DW; Pandya S; Yang M; Cunniff C J Pediatr; 2013 Oct; 163(4):1080-4.e1. PubMed ID: 23866715 [TBL] [Abstract][Full Text] [Related]
15. The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review. Szabo SM; Salhany RM; Deighton A; Harwood M; Mah J; Gooch KL Orphanet J Rare Dis; 2021 May; 16(1):237. PubMed ID: 34022943 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of care practices for young boys with Duchenne muscular dystrophy between Japan and European countries: Implications of early diagnosis. Takeuchi F; Komaki H; Yamagata Z; Maruo K; Rodger S; Kirschner J; Kubota T; Kimura E; Takeda S; Gramsch K; Vry J; Bushby K; Lochmüller H; Wada K; Nakamura H Neuromuscul Disord; 2017 Oct; 27(10):894-904. PubMed ID: 28807665 [TBL] [Abstract][Full Text] [Related]
17. Time to diagnosis of Duchenne muscular dystrophy remains unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000-2015. Thomas S; Conway KM; Fapo O; Street N; Mathews KD; Mann JR; Romitti PA; Soim A; Westfield C; Fox DJ; Ciafaloni E; Muscle Nerve; 2022 Aug; 66(2):193-197. PubMed ID: 35312090 [TBL] [Abstract][Full Text] [Related]
19. De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany. König K; Pechmann A; Thiele S; Walter MC; Schorling D; Tassoni A; Lochmüller H; Müller-Reible C; Kirschner J Orphanet J Rare Dis; 2019 Jun; 14(1):152. PubMed ID: 31234869 [TBL] [Abstract][Full Text] [Related]
20. Burden of Disease of Duchenne Muscular Dystrophy in Denmark - A National Register-Based Study of Individuals with Duchenne Muscular Dystrophy and their Closest Relatives. Rudolfsen JH; Vissing J; Werlauff U; Olesen C; Illum N; Olsen J; Poulsen PB; Strand M; Born AP J Neuromuscul Dis; 2024; 11(2):443-457. PubMed ID: 38217608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]